PharmaCyte Biotech Inc (NASDAQ:PMCB)
| 3.03 Delayed Data As of Nov 25 |  -0.04 / -1.30%Today’s Change | 1.79 Today|||52-Week Range 3.10 | +21.20% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP -- |
Company Description
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.
Contact Information
PharmaCyte Biotech, Inc. 3960 Howard Hughes Parkway Las Vegas Nevada 89169 |
Employees
Shareholders
| Mutual fund holders | 4.30% |
| Other institutional | 26.20% |
| Individual stakeholders | 0.73% |
Top Executives
| Joshua Nathaniel Silverman | Chairman, President & Chief Executive Officer |
| Carlos A. Trujillo | Chief Financial Officer |
| José L. Iglesias | Chief Medical Officer |
| Lilli Brandtner | Director-Diabetes Program Development |
